1. Home
  2. MBC vs SDGR Comparison

MBC vs SDGR Comparison

Compare MBC & SDGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo MasterBrand Inc.

MBC

MasterBrand Inc.

HOLD

Current Price

$7.21

Market Cap

1.6B

Sector

Industrials

ML Signal

HOLD

Logo Schrodinger Inc.

SDGR

Schrodinger Inc.

HOLD

Current Price

$29.23

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MBC
SDGR
Founded
1954
1990
Country
United States
United States
Employees
N/A
N/A
Industry
Agricultural Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.5B
IPO Year
2022
2020

Fundamental Metrics

Financial Performance
Metric
MBC
SDGR
Price
$7.21
$29.23
Analyst Decision
Strong Buy
Buy
Analyst Count
1
9
Target Price
$15.00
$21.00
AVG Volume (30 Days)
2.3M
1.8M
Earning Date
05-05-2026
05-05-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
45.14
EPS
N/A
N/A
Revenue
$2,734,700,000.00
$255,869,000.00
Revenue This Year
N/A
$0.76
Revenue Next Year
$2.55
$4.60
P/E Ratio
N/A
N/A
Revenue Growth
1.27
23.29
52 Week Low
$6.27
$10.95
52 Week High
$13.96
$31.59

Technical Indicators

Market Signals
Indicator
MBC
SDGR
Relative Strength Index (RSI) 39.28 76.61
Support Level $6.61 $11.27
Resistance Level $9.55 N/A
Average True Range (ATR) 0.43 1.73
MACD -0.03 1.00
Stochastic Oscillator 34.53 89.36

Price Performance

Historical Comparison
MBC
SDGR

About MBC MasterBrand Inc.

MasterBrand Inc operates as a residential cabinet manufacturer in North America. It offers a comprehensive portfolio of residential cabinetry products for the kitchen, bathroom, and other parts of the home. The firm sells its products throughout the United States and Canada through three primary channels: dealers, retailers and builders.

About SDGR Schrodinger Inc.

Schrodinger Inc is a healthcare-based software company. It offers software solutions designed to support and accelerate the discovery, design, and optimization of molecules. The company operates in two reportable segments: Software and Drug Discovery. The software segment is focused on selling software to transform drug discovery across the life sciences industry, as well as to customers in materials science industries. The drug discovery segment is focused on generating revenue from a diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have various stages of discovery and development. The majority of the company's revenue is derived from the Software segment. Geographically, it derives the maximum revenue from the United States.

Share on Social Networks: